Name: Bioworkshops sell "Ocrelizumab"
Brand: Bioworkshops
Availability: InStock

1.3K

4.3(14)

Category

Subcategory & Sub-subcategory

Trade Type

Sell

Product Name

Ocrelizumab

Manufacturer(s)

Specifications

Expression System: Optimized mammalian (CHO) cell line supported by a Drug Master File (DMF) filing, delivering consistently high titers for cost-efficient large-scale manufacturing.
Regulatory Status: Cell line developed with global regulatory readiness in mind (DMF filing) to streamline submissions for this CD20-directed mAb biosimilar (reference product first approved 2017-03-28, US).
Application: CD20-directed monoclonal antibody biosimilar for immune-mediated and nervous system diseases, notably relapsing and primary progressive multiple sclerosis.
Purity: Proven high degree of analytical comparability (similarity) to the reference product, supporting regulatory and clinical acceptance as a biosimilar.

Bioworkshops sell "Ocrelizumab"

Ratings